Publication | Open Access

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial

MedicineImmunologyClinical TrialsVaccine TrialPhase IibBlp25 Liposome VaccineCancer TreatmentImmunotherapyOncologyRadiation OncologyLung CancerHealth Sciences